A detailed history of Bay Bridge Capital Group, LLC transactions in Liquidia Corp stock. As of the latest transaction made, Bay Bridge Capital Group, LLC holds 8,740 shares of LQDA stock, worth $249,789. This represents 0.19% of its overall portfolio holdings.

Number of Shares
8,740
Holding current value
$249,789
% of portfolio
0.19%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 16, 2026

BUY
$21.9 - $28.58 $191,406 - $249,789
8,740 New
8,740 $301 Million

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $1.84B
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Bay Bridge Capital Group, LLC Portfolio

Follow Bay Bridge Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bay Bridge Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bay Bridge Capital Group, LLC with notifications on news.